INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA


Werte in diesem Artikel
Aktien

19.99 EUR 0.22 EUR 1.14 %

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether STAAR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On February 11, 2025, STAAR issued a press release reporting its financial results for the fourth quarter and full year 2024.  Among other items, for the quarter, STAAR reported GAAP earnings per share of -$0.69, missing consensus estimates by $0.55, and revenue of $48.95 million, missing consensus estimates by $28.52 million.  The Company attributed its results to "fluctuating demand in China". 

On this news, STAAR's stock price fell $5.40 per share, or 24.68%, to close at $16.48 per share on February 12, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-staar-surgical-company---staa-302385055.html

SOURCE Pomerantz LLP

Aktuelle STAAR Surgical Company Aktie News

Werbung

STAAR Surgical Company Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für STAAR Surgical Company nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
24.09.18 STAAR Surgical Company Buy The Benchmark Company
06.08.18 STAAR Surgical Company Buy The Benchmark Company
20.11.17 STAAR Surgical Company Buy The Benchmark Company
14.08.17 STAAR Surgical Company Buy The Benchmark Company
03.03.17 STAAR Surgical Company Buy The Benchmark Company

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.